Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 48 citing articles:

Beyond the pancreas: contrasting cardiometabolic actions of GIP and GLP1
Rola Hammoud, Daniel J. Drucker
Nature Reviews Endocrinology (2022) Vol. 19, Iss. 4, pp. 201-216
Closed Access | Times Cited: 128
Obesity and MASLD: Is weight loss the (only) key to treat metabolic liver disease?
Maximilian Huttasch, Michael Roden, S. Kahl
Metabolism (2024) Vol. 157, pp. 155937-155937
Open Access | Times Cited: 34
Interplay of fatty acids, insulin and exercise in vascular health
Kara C. Anderson, Jia Liu, Zhenqi Liu
Lipids in Health and Disease (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Coronary Microvascular Dysfunction in Diabetes Mellitus: Pathogenetic Mechanisms and Potential Therapeutic Options
Teresa Salvatore, Raffaele Galiero, Alfredo Caturano, et al.
Biomedicines (2022) Vol. 10, Iss. 9, pp. 2274-2274
Open Access | Times Cited: 54
GLP1 Receptor Agonists—Effects beyond Obesity and Diabetes
Sydney S. Wilbon, Mikhail G. Kolonin
Cells (2023) Vol. 13, Iss. 1, pp. 65-65
Open Access | Times Cited: 27
Effects of GLP-1 receptor agonists and SGLT-2 inhibitors on cardiac structure and function: a narrative review of clinical evidence
Andrea Natali, Lorenzo Nesti, Domenico Tricò, et al.
Cardiovascular Diabetology (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 44
Repurposing Drugs for Diabetes Mellitus as Potential Pharmacological Treatments for Sarcopenia – A Narrative Review
Miles D. Witham, Antoneta Granic, Ewan R. Pearson, et al.
Drugs & Aging (2023) Vol. 40, Iss. 8, pp. 703-719
Open Access | Times Cited: 17
Intermediate versus morning chronotype has lower vascular insulin sensitivity in adults with obesity
Steven K. Malin, Mary‐Margaret E. Remchak, Emily M. Heiston, et al.
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. 5, pp. 1582-1592
Closed Access | Times Cited: 6
Impact of Selected Glucagon-like Peptide-1 Receptor Agonists on Serum Lipids, Adipose Tissue, and Muscle Metabolism—A Narrative Review
Zsolt Szekeres, András Nagy, K. Jahner, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8214-8214
Open Access | Times Cited: 6
Diabetes pathogenesis and management: the endothelium comes of age
Kaitlin M. Love, Eugene J. Barrett, Steven K. Malin, et al.
Journal of Molecular Cell Biology (2021) Vol. 13, Iss. 7, pp. 500-512
Open Access | Times Cited: 33
Oral Semaglutide Induces Loss of Body Fat Mass Without Affecting Muscle Mass in Patients With Type 2 Diabetes
Syutaro Uchiyama, Yukiyoshi Sada, Syohei Mihara, et al.
Journal of Clinical Medicine Research (2023) Vol. 15, Iss. 7, pp. 377-383
Open Access | Times Cited: 16
Liraglutide and Exercise Synergistically Attenuate Vascular Inflammation and Enhance Metabolic Insulin Action in Early Diet-Induced Obesity
Jia Liu, Kevin W. Aylor, Zhenqi Liu
Diabetes (2023) Vol. 72, Iss. 7, pp. 918-931
Open Access | Times Cited: 13
Insights into the role of obesity in Heart Failure with Preserved Ejection Fraction pathophysiology and management
Brandon Hathorn, Mark J. Haykowsky, Jaime P. Almandoz, et al.
Canadian Journal of Cardiology (2025)
Closed Access
GLP-1 Receptor Agonists and Myocardial Perfusion: Bridging Mechanisms to Clinical Outcomes
Paschalis Karakasis, Dimitrios Patoulias, Panagiotis Theofilis, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 3050-3050
Open Access
Effect of Hypoglycemic Drugs on Patients with Heart Failure with or without T2DM: A Bayesian Network Meta-analysis
Zhaolun Zhang, Su‐Hsun Liu, Jiawen Xian, et al.
Reviews in Cardiovascular Medicine (2025) Vol. 26, Iss. 3
Open Access
A narrative review of exercise participation among adults with prediabetes or type 2 diabetes: barriers and solutions
Samantha C. Thielen, Jane E.B. Reusch, Judith G. Regensteiner
Frontiers in Clinical Diabetes and Healthcare (2023) Vol. 4
Open Access | Times Cited: 9
Curbing the Obesity Epidemic: Should GLP-1 Receptor Agonists Be the Standard of Care for Obesity?
Jennifer M. Kaplan, Adnin Zaman, Layla A. Abushamat
Current Cardiology Reports (2024) Vol. 26, Iss. 9, pp. 1011-1019
Closed Access | Times Cited: 3
Liraglutide Accelerates Ischemia‐Induced Angiogenesis in a Murine Diabetic Model
Yu‐xin Zhu, Yi Li, Yu Ma, et al.
Journal of the American Heart Association (2023) Vol. 12, Iss. 4
Open Access | Times Cited: 8
GLP‐1 and insulin regulation of skeletal and cardiac muscle microvascular perfusion in type 2 diabetes
Kaitlin M. Love, Jia Liu, Judith G. Regensteiner, et al.
Journal of Diabetes (2020) Vol. 12, Iss. 7, pp. 488-498
Open Access | Times Cited: 23
GLP-1 Receptor Agonists and Coronary Arteries: From Mechanisms to Events
Aurélie Pahud de Mortanges, Eldem Sinaci, Dante Salvador, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 13
The impact of GLP-1 signalling on the energy metabolism of pancreatic islet β-cells and extrapancreatic tissues
Leah A. Peart, Matthew Draper, Andrei I. Tarasov
Peptides (2024) Vol. 178, pp. 171243-171243
Closed Access | Times Cited: 2
Mechanistic Causes of Reduced Cardiorespiratory Fitness in Type 2 Diabetes
Layla A. Abushamat, P. Mason McClatchey, Rebecca L. Scalzo, et al.
Journal of the Endocrine Society (2020) Vol. 4, Iss. 7
Open Access | Times Cited: 18
Oral and intravenous glucose administration elicit opposing microvascular blood flow responses in skeletal muscle of healthy people: role of incretins
Katherine M. Roberts‐Thomson, Lewan Parker, Andrew C. Betik, et al.
The Journal of Physiology (2022) Vol. 600, Iss. 7, pp. 1667-1681
Open Access | Times Cited: 12
Diabetes Pharmacotherapy and its effects on the Skeletal Muscle Energy Metabolism
Baowen Yu, Dong Wang, Junming Zhou, et al.
Mini-Reviews in Medicinal Chemistry (2024) Vol. 24, Iss. 16, pp. 1470-1480
Closed Access | Times Cited: 2
Microvascular Dysfunction in Obesity-Hypertension
Tammy Do, Ashley Van, A Ataei, et al.
Current Hypertension Reports (2023) Vol. 25, Iss. 12, pp. 447-453
Closed Access | Times Cited: 5
Page 1 - Next Page

Scroll to top